Lateral flow assays, consisting of membranes, antibodies and reagents, are used to confirm the presence or absence of a target analyte which is detected by a color change or fluorescent dye. The development of these assays has allowed for the low cost and effective large-scale screening of various infectious diseases, including COVID-19, with high specificity.
Download this whitepaper to discover assay development tools that can help you to:
- Image various dyes with different excitation and emission wavelengths
- Achieve a high degree of photostability and specific targeting
- Detect the presence of proteins, including SARS-CoV-2’s spike protein